ReviewNature reviews. Urology2026
Animal models of spinal cord injury in neuro-urological research.
Review in Nature reviews. Urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord injury (SCI) is a life-changing and costly condition. SCI causes major disturbances in sensory, motor and autonomic function, resulting in permanent loss of function and strongly affecting the physical, psychological and social well-being of patients and caregivers. A particularly debilitating consequence of SCI is loss of voluntary control over bladder function, which substantially affects patients' dignity, health and quality of life. Current understanding of the complex pathophysiological mechanisms of SCI and associated comorbidities has heavily relied on the use of animal models, which have also been crucial in devising new therapeutic approaches and fine-tuning existent ones. However, a debate about the persistent challenges in translating preclinical data into treatment is ongoing. Technological advances are generating innovative modelling approaches with the support of regulatory bodies, aiming to reduce or eventually substitute animal use. In this Review, we address the current use of animal SCI models in neuro-urological research and debate whether we will still be using these models by 2035.
Identifiers
42321369What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.